Adjuvants — a balance between toxicity and adjuvanticity
- 1 January 1993
- Vol. 11 (3) , 293-306
- https://doi.org/10.1016/0264-410x(93)90190-9
Abstract
No abstract availableKeywords
This publication has 157 references indexed in Scilit:
- Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old childrenThe Journal of Pediatrics, 1988
- Effectiveness of antitumor low dose chemotherapy is increased by combination with immunotherapyInternational Journal of Immunopharmacology, 1985
- Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivativeInternational Journal of Immunopharmacology, 1982
- Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouseInternational Journal of Immunopharmacology, 1979
- Immunoadjuvant activity of synthetic N-acetyl muramyl dipeptideCellular and Molecular Life Sciences, 1978
- New aspects of liposomesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1976
- Total synthesis and adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1975
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974
- Variability of the potency of pertussis vaccinein relation to the number of bacteriaThe Journal of Pediatrics, 1954
- Sur la constitution chimique des acides mycoliques de deux souches humaines virulentes de Mycobacterium tuberculosisBiochimica et Biophysica Acta, 1951